Navigation Links
SyntheMed, Inc. Adopts Shareholder Rights Plan
Date:5/20/2008

ISELIN, N.J., May 20 /PRNewswire-FirstCall/ -- SyntheMed, Inc. (OTC Bulletin Board: SYMD) announced today that its Board of Directors approved the adoption of a shareholder rights plan. The shareholder rights plan is designed to ensure that shareholders realize fair value and equal treatment in the event of an attempted takeover of the company and to protect the company and its shareholders against coercive takeover tactics. The plan was not approved for adoption as a result of any specific takeover attempt.

To implement the shareholder rights plan, the Board of Directors has declared a dividend distribution of one right for each share of SyntheMed common stock outstanding as of the close of business on June 2, 2008. Initially, the rights will be represented by SyntheMed common stock certificates, will not be traded separately from the common stock and will not be exercisable. The rights generally will become exercisable following any person becoming an "acquiring person" by acquiring, or commencing a tender offer to acquire, beneficial ownership of 15% or more of the outstanding shares of SyntheMed common stock. If a person becomes an "acquiring person," each holder of a right, other than the acquirer, would be entitled to receive, upon payment of the then purchase price, a number of shares of SyntheMed common stock or other securities having a value equal to twice the purchase price. If SyntheMed is acquired in a merger or other business combination transaction after any such event, each holder of a right, other than the acquirer, would be entitled to receive, upon payment of the then purchase price, shares of the acquiring company having a value equal to twice the purchase price. The rights are scheduled to expire on June 2, 2018 unless earlier redeemed, terminated or exchanged in accordance with the terms of the shareholder rights plan.

In connection with the adoption of the rights plan, a committee of the Board of Directors comprised of ind
'/>"/>

SOURCE SyntheMed, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Haemonetics Chairman and CEO Adopts 10b5-1 Stock Trading Plan
2. Virginias largest Cardiac Surgery program adopts SPY as standard of care
3. Edwards Lifesciences Chairman and CEO Adopts New 10b5-1 Stock Trading Plan to Replace Recently Expired Plan
4. Indiana Adopts Legislation to Combat Illegitimate Online Pharmacies, Protect Residents From Counterfeit Drugs
5. Weight Watchers COO Adopts 10b5-1 Trading Plan
6. Masimo Corporation Adopts Stockholder Rights Plan
7. APHA Adopts New Policies on Food Safety, Global Climate Change, Multidrug-Resistant Organisms, Breastfeeding and Feminine Hygiene
8. Texas Health and Human Services Commission Adopts Mediwares ClosedLoop(TM) Medication Management Strategy
9. Haemacure Adopts Strategy for "First-Patient-In" Fibrin Sealant Pivotal Clinical Trials
10. Aionex Adopts SkyeTeks Embedded RFID Solution to Ensure Patient Safety
11. Law Offices of Howard G. Smith Announces 24 Days Remaining to Move to Be a Lead Plaintiff in the Shareholder Lawsuit Against Inverness Medical Innovations, Inc.

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...e patient outcomes, research suggests , ,...ation drug therapy shows promise in treating patie...rs say. , The study from the Massachusetts Gene...rvival and tumor response in patients treated with...that has helped slow the growth of other cancers, ...
(Date:11/23/2009)... get sick, study finds , , MONDAY, Nov. ...netic variation appears to play a major role in sl.... , In fact, those with the variation appear ...mplications of the disease. , "We,re honing i...e a person more or less susceptible to HIV, in ter...
(Date:11/23/2009)...23/PRNewswire/--HealthLeaders-InterStudy,aleadingp...self-insuredmembercompaniesthatarepartofMilwaukee,...healthcare-costdecreaseof1.5percentperhealthplanme...formanceprovidernetwork.Accordingtothe MilwaukeeMa...mbercompaniessaved$44millioninhealthcarecostsovert...
(Date:11/23/2009)...re-FirstCall/-- ,, DearIsisSupportersandShareho...continuingsupportofIsis.Webelieveweareatoneofthemo...ofthebeginningofcreatingauniquecompanywithanoveldr...heissueshauntingthepharmaceuticalindustry. ,, O...agshipdrug,mipomersen.Mipomersencontinuestoperform...
(Date:11/23/2009)...erylCompanies,thenation,sleadingproviderofoutsourc...rnedrecognitionasoneofthetopoutsourcingfirmsinheal...demagazine.Berylwasrankedamongthepublication,stop2...,whichenabledittoclimbfromtwelfthplacein2007totent...tiveproducts,suchasitsnewestlaunchofpost-discharge...
Breaking Medicine News(10 mins):Health News:Combo Treatment Beneficial in Biliary-Tract Cancer Study 2Health News:Genetic Variant Slows AIDS Progression 2Health News:Milwaukee Employers See Cost Savings with High-Performance Provider Network 2Health News:The Beryl Companies Named One of the 'Top 10 Outsourcing Firms' in Healthcare 2
..., PhD, FNP Join Together to Raise Awareness of Com... , ANAHEIM, Calif., May 12 Fibromyalgia is often...who have it typically do not look sick. However, ...e U.S., affecting more than five million Americans...
...e.com, Recommended to Help Guide Important Convers...nosis , , NEW YORK, May 12 The multi-disciplina...ase Screening Discussion Group (ADSDG) is calling ...,s disease (AD) symptoms. The goal of the call-to-...
...nce, Biomarker Strategies and Pharma on Panel , ,...nc. (NYSE Amex: ILI ) announced today that CEO L...l discussion titled "Integrating Genetic Markers i...anta, GA. The panel discussion will be held Tuesd...
... Inc., the leading provider of pathway data minin...ion, the premiere visualization and analysis softw...a, today announced the integration of the MetaCore...tion will benefit," said Julie Bryant, VP of Busin...
...he rating agency,Standard & Poor,s has today c...eimer Group and continues to categorize the outloo...pharma & life science industry is therefore,as...urope,America and Asia. In the financial year 2008...
...emier medical and surgical equipment supplier, now...nt monitors that feature clinically-proven techno... , (Vocus) May 12, 2009 --...de the DRE ASM 6000 and DRE ASM 6000 Pro, sleek pa...
Other Medicine News:Health News:VIDEO from Medialink, the National Fibromyalgia Association and Pfizer: The Painful Truth about Fibromyalgia 2Health News:Experts Urge Family Members and Friends to Seek Immediate Intervention for Their Loved Ones Who May Have Alzheimer's Disease (AD) 2Health News:Experts Urge Family Members and Friends to Seek Immediate Intervention for Their Loved Ones Who May Have Alzheimer's Disease (AD) 3Health News:Experts Urge Family Members and Friends to Seek Immediate Intervention for Their Loved Ones Who May Have Alzheimer's Disease (AD) 4Health News:Experts Urge Family Members and Friends to Seek Immediate Intervention for Their Loved Ones Who May Have Alzheimer's Disease (AD) 5Health News:Interleukin Genetics to Chair Expert Panel Discussion on Use of Biomarkers in Drug Development at BIO Convention 2Health News:Interleukin Genetics to Chair Expert Panel Discussion on Use of Biomarkers in Drug Development at BIO Convention 3Health News:GeneGo and OmicSoft Announce Integration 2Health News:GeneGo and OmicSoft Announce Integration 3Health News:DRE Medical Equipment Releases New Multi-Function Patient Monitors 2
(Date:11/23/2009)...e/--BioTrendsResearchGroup,Inc.releasedWave2ofits ...amulti-phasesyndicatedmarketresearchprojecttrackin...hthefirstsixmonthsofproductavailability.Eachwaveof...ueNephrologistsandqualitativeinformationfromasubse...lestouse,reasonstouse,typicalpatienttypes,productp...
(Date:11/23/2009)...ewswire-FirstCall/--WoundManagementTechnologies,In...fspecialtymedicalproducts,announcedthatithasfiledi...emanagementbusinessupdatetoillustratethedevelopmen...reased33.5%to$102,926vs.Q32008salesof$77,084. ,...,892vs.Q32008shareholderequityof$(321,257) , ...
(Date:11/23/2009)...wire/--AMDLASERSannouncedthisweekthatitcontinueswi...withprestigiousindustry-leaderDr.LarryRosenthaland...clusivesofttissuediodelaserusedduringallinternatio...%ofdentists. ,, (Photo: http://www.newscom.com/...atpleasurethatIproudlyannounceourpartnership.Softt...
Breaking Medicine Technology:Reported Use of AMAG's Feraheme (ferumoxytol) Continues To Be Low, But a Number of Nephrologists Are 'On the Verge' of Use 2Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 2Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 3Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 4Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 5AMD LASERS Announces New Partnership with Dr. Larry Rosenthal and Aesthetic Advantage 2New device finds early signs of eye disease in preemies 57843 1New device finds early signs of eye disease in preemies 57843 2NOAA and partners complete restoration project in Hempstead Harbor 10009 1NOAA and partners complete restoration project in Hempstead Harbor 10009 2Insufficient levels of vitamin D puts elderly at increased risk of dying from heart disease 10005 1Insufficient levels of vitamin D puts elderly at increased risk of dying from heart disease 10005 2
...TIPOLIS, France, Oct. 2 NicOx S.A.,(Eurolist: COX...inical and,preclinical results from its collaborat...rld Congress of Dermatology, in Buenos Aires, Arge..., a prototype compound, showing,the potential for ...esults,for a novel, high potency, nitric oxide-don...
... Oct. 1 Keryx Biopharmaceuticals,Inc. (Nasdaq: K... the,Company,s President, will present an overview...William Blair & Company Small-Cap Growth Stock,Con...tion will take place,on Wednesday, October 3rd at ... webcast live and will be,accessible from the Inve...
Other Medicine Technology:NicOx and Ferrer Present Promising Clinical and Preclinical Results in Dermatology 2NicOx and Ferrer Present Promising Clinical and Preclinical Results in Dermatology 3Keryx Biopharmaceuticals to Present at William Blair & Company Small-Cap Growth Stock Conference 2
Disposable Caps and Plugs
Bivona® Uncuffed Pediatric FlexTend™ Plus Standard Tracheostomy Tubes
Bivona® TTS™ Cuffed Pediatric Tracheostomy Tubes
Portex® Extra Length Pediatric Tracheostomy Tubes with 15 mm Connector
Medicine Products: